Is the rise of GLP-1 usage affecting long-term affordability?

The average total payment per user for GLP-1 medications more than doubled for adults who don't have diabetes from 2017 to 2022.

The post Is the rise of GLP-1 usage affecting long-term affordability? appeared first on HR Executive.